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Abstract: Monocytes and macrophages express a repertoire of cell surface P2 receptors for adenosine
5′-triphosphate (ATP) a damage-associated molecular pattern molecule (DAMP), which are capable
of raising cytoplasmic calcium when activated. This is achieved either through direct permeation
(ionotropic P2X receptors) or by mobilizing intracellular calcium stores (metabotropic P2Y receptors).
Here, a side-by-side comparison to investigate the contribution of P2X4 receptor activation in
ATP-evoked calcium responses in model human monocytes and macrophages was performed.
The expression of P2X1, P2X4, P2X5 and P2X7 was confirmed by qRT-PCR and immunocytochemistry in
both model monocyte and macrophage. ATP evoked a concentration-dependent increase in intracellular
calcium in both THP-1 monocyte and macrophages. The sarco/endoplasmic reticulum Ca2+-ATPase
inhibitor thasigargin (Tg) responses to the maximal ATP concentration (100 µM) in THP-1 monocytes,
and responses in macrophage were significantly attenuated. Tg-resistant ATP-evoked calcium responses
in the model macrophage were dependent on extracellular calcium, suggesting a requirement for calcium
influx. Ivermectin (IVM) potentiated the magnitude of Tg-resistant component and slowed the decay of
response in the model macrophage. The Tg-resistant component was attenuated by P2X4 antagonists
5-BDBD and PSB-12062 but not by the P2X1 antagonist Ro0437626 or the P2X7 antagonist A438079.
shRNA-mediated P2X4 knockdown resulted in a significant reduction in Tg-resistant ATP-evoked
calcium response as well as reduced sensitivities towards P2X4-specific pharmacological tools, IVM and
PSB-12062. Inhibition of endocytosis with dynasore significantly reduced the magnitude of Tg-resistant
component but substantially slowed decay response. Inhibition of calcium-dependent exocytosis with
vacuolin-1 had no effect on the Tg-resistant component. These pharmacological data suggest that P2X4
receptor activation contributed significantly towards the ionotropic calcium response evoked by ATP of
the model human macrophage.
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1. Introduction
The release of adenosine 5′-triphosphate (ATP) as a signaling molecule by activated leukocytes,
platelets and apoptotic cells is crucial for the induction of a variety of physiological responses across
different cell types [1,2]. ATP is able to mediate these biological processes through the activation of
purinergic P2 receptors: P2X (ligand-gated ion channels) or P2Y (G-protein coupled receptors) [3,4].
To date, seven mammalian P2X receptor subunits (P2X1–P2X7) have been identified with widespread
distribution throughout neuronal and non-neuronal tissues [5]. The expression of P2X receptors has
been reported in immune cells such as monocytes and macrophages, with P2X4 and P2X7 being the
pre-dominant subunits expressed [6]. Although significant research has been performed in the past
decade to elucidate a role of P2X7 receptor in the immune system, the same cannot be said for the
P2X4 receptor. Research on the P2X4 receptor has been greatly hampered by the lack of selective
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P2X4 receptor antagonists as well as the possible complicating presence of the P2X7 receptor [7].
In macrophages and microglia, P2X4 receptors have been shown to co-express with P2X7 receptors,
although they do not appear to share the same downstream signaling pathways [8,9].
Although the role of P2X4 receptors in monocytes and macrophages is not clearly defined
within the literature, P2X4 expression has been shown to be upregulated following nerve damage in
microglia [10] and, in macrophages, P2X4 has been reported to mediate prostaglandin E2 (PGE2)
release [11]. Studies by Li and Fountain (2012) in THP-1 monocytes also illustrated that P2X4
contributes towards the ATP-evoked Ca2+ response and that its activity is suppressed by cholesterol
lowering drug, fluvastatin [12].
In the present study, we have performed a side-by-side comparison of the expression of
P2X receptors in model human THP-1 monocytes and macrophages through the use of qRT-PCR
and immunocytochemistry. Though evidence of functional P2X4 can be revealed by whole-cell
patch-clamps, studies evaluating the role of P2X receptors in intact cells are limited. To this end,
we investigated the contribution of P2X4 receptor activation towards ATP-evoked intracellular Ca2+
response, and this was assessed in the two cell models through intracellular Ca2+ measurements.
Our findings allowed the identification of P2X4 contribution of towards ATP-evoked Ca2+ influx
in model human monocytes and macrophages, while also assessing the reliability of commercially
available pharmacological tools for the study of P2X4.
2. Results
P2X1, P2X4, P2X5 and P2X7 are expressed at the mRNA and protein level in THP-1 monocytes
and macrophages. Expression of P2X receptors in human THP-1 monocytes and THP-1 differentiated
macrophages were investigated at the mRNA and protein level. qRT-PCR analysis identified mRNA
expression of all P2X genes with the exception of P2X2 in THP-1 and P2X2 and P2X3 in THP-1
differentiated macrophages (Figure 1A). Fold change in mRNA expression was also quantified and
showed that, across three replicates, P2X1 and P2X2 mRNA expression was found to be downregulated
(P2X1: 0.38 ± 0.058 fold; n = 5; p < 0.001 and P2X2: 0.13 ± 0.074 fold; n = 5; p < 0.001), while P2X4
were found to be upregulated (2.61 ± 0.52 fold; n = 5; p < 0.05) in THP-1-differentiated macrophages
compared to THP-1 monocytes (Figure 1B). Using immunocytochemistry, protein expression of P2X
receptors was also studied. P2X1, P2X4, P2X5 and P2X7 were all expressed in both THP-1 monocytes
and THP-1-differentiated macrophages (Figure 1C,D, respectively).
2.1. ATP-Evoked Intracellular Ca2+ Responses in THP-1 Monocytes and Macrophage Models
ATP evoked a concentration-dependent increase in intracellular Ca2+ response in both THP-1
monocytes (EC50 = 0.174 ± 0.01 µM with extracellular Ca2+ and EC50 = 0.051 ± 0.005 µM without
extracellular Ca2+) (Figure 2A,B) and THP-1-differentiated macrophages (EC50 = 6.25 ± 1.92 µM with
extracellular Ca2+ and EC50 = 14.9± 0.88 µM without extracellular Ca2+; n = 6) (Figure 2C,D). Response to
ATP (100 µM) was biphasic; in both cell types, the response involved an initial rapid increase in
intracellular Ca2+ response, which peaked and was followed by a decay phase. While the response
decayed back to the baseline level in THP-1-differentiated macrophages, the decay response remained
at an elevated phase in THP-1 monocytes (Figure 2B,D). Two striking differences were observed in
the phenotypic features of the ATP-evoked Ca2+ response in the two cell models: (1) peak magnitude
was significantly higher in THP-1 monocytes compared to THP-1-differentiated macrophages (F ratio
3.24± 0.127 THP-1 monocytes vs. 1.09± 0.077 THP-1-differentiated macrophages; n = 12 and 8; p < 0.001;
Figure 2B) and (2) decay response. The decay time was quantified for both cells and illustrated a
much faster decaying response in THP-1-differentiated macrophages (84.0 ± 5.28 s THP-1 monocytes
vs. 18.64 ± 2.18 s THP-1-differentiated macrophages; Figure 2E). Cell quantification throughout
the intracellular Ca2+ assay using Hoechst stain H33342 showed no significant differences in the
number of cells used throughout the experiments, eliminating the possibility that the difference in
peak magnitude in the two cell types were due to difference in cell number (Figure 2F).
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Figure 1. Expression of P2X receptors in THP-1 monocytes and THP-1-differentiated macrophages. 
(A) table showing qRT-PCR Ct values to identify which P2X genes are expressed in THP-1 cells and 
THP-1 differentiated macrophages. Ct values above 35.0 were considered absent (n = 3). Undetected 
genes are represented as N/A; (B) fold change in mRNA expression of P2X receptor genes in THP-1 
differentiated macrophages, normalized to β-actin and THP-cells (n = 3). Asterisks include significant 
changes towards control (*** p < 0.001, * p < 0.05); (C,D) immunocytochemistry of P2X receptor 
expression in THP-1 monocytes and THP-1 differentiated macrophages, respectively, as observed 
under confocal microscopy. Blue represents 2-4(amidinophenyl)-1H-indole-6-carboxamidine (DAPI) 
nuclear stain while green represents human P2X receptor conjugated with AF488. Scale bar represents 
10 μm. Images are representative of n = 3 replicates. TDM: THP-1 differentiated macrophages. 
 
Figure 1. Expression of P2X receptors in THP-1 monocytes and THP-1-differentiated macrophages.
(A) table showing qRT-PCR Ct values to identify which P2X genes are expressed in THP-1 cells and
THP-1 differentiated macrophages. Ct values above 35.0 were considered absent (n = 3). Undetected
genes are represented as N/A; (B) fold change in mRNA expression of P2X receptor genes in THP-1
differentiated macrophages, normalized to β-actin and THP-cells (n = 3). Asterisks include significant
changes towards control (*** p < 0.001, * p < 0.05); (C,D) i munocytochemistry of P2X eceptor
expression in THP-1 ono ytes and THP-1 differentiated macrophages, respectively, as observed
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nuclear stain while green represents human P2X receptor conjugated with AF488. Scale bar represents
10 µm. Images are representative of n = 3 replicates. TDM: THP-1 differentiated macrophages.
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Figure 2. ATP-evoked intracellular Ca2+ responses in THP-1 monocytes and THP-1 differentiated 
macrophages. Concentration response curve of ATP (0.01–1000 μM) in the presence and absence of 
extracellular Ca2+ and its representative traces at 100 μM ATP in: (A,B) THP-1 cells (n = 3) and (C,D) 
THP-1 differentiated macrophages (n = 3); (C) bar chart representing decay kinetics of THP-1 cells  
(n = 12) and THP-1 differentiated macrophages (n = 6); (D,E) difference in decay time of 100 μM-
evoked Ca2+ response in THP-1 versus TDM cells. Tau (τ) is the time constant calculated from fitting 
a single exponential decay to the falling phase of Ca2+ response (n = 5); (F) cell quantification assay 
using nuclear stain H-33342. Asterisks include significant changes towards control (*** p < 0.001,  
n = 4). TDM: THP-1 differentiated macrophages. 
2.2. Dependency of ATP-Evoked Ca2+ Response on ER Calcium Store 
As ATP evoked a global intracellular Ca2+ response, mediated by both the activation of P2X and 
P2Y receptors, a sarco/endoplasmic reticulum Ca2+-ATPase inhibitor, Thapsigargin (Tg), was 
employed to eliminate metabotropic responses. Tg depletes intracellular stores of Ca2+ resulting in a 
raise in cytosolic Ca2+ level (F ratio 1.35 ± 0.0082 without Tg vs. 2.24 ± 0.065 with Tg; n = 6; p < 0.001; 
Figure 3). Pre-treatment of cells with 5 μM Tg completely attenuated ATP-evoked intracellular Ca2+ 
response in THP-1 monocytes (Figure 3A,B) while significantly inhibiting ATP-evoked intracellular 
Ca2+ response in THP-1-differentiated macrophages (88.7 ± 3.29% inhibition; n = 6; p < 0.001)  
(Figure 3C,D). Despite a significant inhibition with Tg, the results showed that 11.3 ± 3.29% (n = 6) of 
the ATP-evoked Ca2+ response appeared to be resistant to Tg. In the absence of extracellular Ca2+, this 
Tg-resistant Ca2+ response was completely abolished, implying that it is dependent on Ca2+ influx 
(Figure 3E). 
2.3. P2X4, but not P2X1 or P2X7, Receptor Activation Mediates the Ionotropic Calcium Response in Model 
Human Macrophage 
The contribution of P2X4 receptor activation towards Tg-resistant ATP-evoked Ca2+ response 
was studied using a combination of pharmacological tools. Pre-treatment of cells with P2X4-specific 
positive allosteric modulator (ivermectin (IVM); 3 μM) resulted in the potentiation of peak magnitude 
of Tg-resistant Ca2+ response by 2.1 fold (F ratio 0.42 ± 0.025 without IVM to 0.90 ± 0.042 with IVM; n 
= 6; p < 0.001) (Figure 4A,B). In addition to this, IVM also significantly delayed the decay kinetics by 
3.67 ± 0.37 fold (14.4 ± 0.78 s without IVM to 49.9 ± 3.8 s with IVM; n = 6; p < 0.001) (Figure 4C). 
Selective P2X4 receptor antagonists, 5-BDBD and PSB-12062, were also used to investigate the 
contribution of P2X4. In the presence of Tg, both 5-BDBD and PSB-12062 (both at 10 μM) caused a 
significant inhibition towards the ATP-evoked Ca2+ response by 52.9 ± 1.99% (n = 3; p < 0.01; Figure 
5A) and 78.5 ± 3.23% (n = 3; p < 0.001; Figure 5C), respectively. In addition to inhibiting the peak 
magnitude of the Tg-resistant Ca2+ response, both antagonists also abolished the second slower 
response observed in the presence of Tg (Figure 5B,D). Finally, pre-treatment of THP-1-differentiated 
macrophages with P2X1 (Ro0437626; 30 μM) or P2X7 (A438079; 5 μM) antagonists had no inhibitory 
effect on Tg-resistant Ca2+ responses (Figure 5E,F, respectively). 
Figure 2. ATP-evoked intracellular Ca2+ responses in THP-1 monocytes and THP-1 differentiated
macrophages. Concentration response curve of ATP (0.01–1000 µM) in the presence and absence of
extracellular Ca2+ and its representative traces at 100 µM ATP in: (A,B) THP-1 cells (n = 3) and (C,D)
THP-1 differentiated macrophages (n = 3); (C) bar chart representing decay kinetics of THP-1 cells
(n = 12) and THP-1 differentiated macrophages (n = 6); (D,E) difference in decay time of 100 µM-evoked
Ca2+ response in THP-1 versus TDM cells. Tau (τ) is the time constant calculated from fitting a single
exponential decay to the falling phase of Ca2+ response (n = 5); (F) cell quantification assay using
nuclear stain H-33342. Asterisks include significant changes towards control (*** p < 0.001, n = 4). TDM:
THP-1 differentiated macrophages.
2.2. Dependency of ATP-Evoked Ca2+ Response on ER Calciu Store
As ATP evoked a global intracellular Ca2+ response, mediated by both the activation of P2X
and P2Y receptors, a sarco/endoplasmic reticulum Ca2+-ATPase inhibitor, Thapsigargin (Tg), was
employed to eliminate metabotropic responses. Tg depletes intracellular stores of Ca2+ resulting in a
raise in cytosolic Ca2+ level (F ratio 1.35 ± 0.0082 without Tg vs. 2.24 ± 0.065 with Tg; n = 6; p < 0.001;
Figure 3). Pre-treatment of cells with 5 µM Tg completely attenuated ATP-evoked intracellular Ca2+
response in THP-1 monocytes (Figure 3A,B) wh le si nificant y inhibiting ATP-evoked intracellular
Ca2+ r sponse in THP-1-differ ntiated macrophages (88.7 ± 3.29% inhibition; n = 6; p < 0.001)
(Figure 3C,D). Despite a significant inhibition with Tg, the results showed that 11.3 ± 3.29% (n = 6)
of the ATP-evoked Ca2+ response appeared to be resistant to Tg. In the absence of extracellular Ca2+,
this Tg-resistant Ca2+ response was completely abolished, implying that it is dependent on Ca2+ influx
(Figure 3E).
2.3. P2X4, but not P2X1 or P2X7, Receptor Acti atio Mediates the Ionotropic Calcium Response in Model
Human Macrophage
The contribution of P2X4 receptor activation towards Tg-resistant ATP-evoked Ca2+ response
was studied using a combination of pharmacological tools. Pre-treatment of cells with P2X4-specific
positive allosteric modulator (ivermectin (IVM); 3 µM) resulted in the potentiation of peak magnitude
of Tg-resistant Ca2+ r sp nse by 2.1 fold (F ratio 0.42 ± .025 without IVM to 0.90 ± 0.042 with
IVM; n = 6; p < 0.001) (Figur 4A,B). In additi n to this, IVM also significantly delayed the decay
kinetics by 3.67 ± 0.37 fold (14.4 ± 0.78 s without IVM to 49.9 ± 3.8 s with IVM; n = 6; p < 0.001)
(Figure 4C). Selective P2X4 receptor antagonists, 5-BDBD and PSB-12062, were also used to investigate
the contribution of P2X4. In the presence of Tg, both 5-BDBD and PSB-12062 (both at 10 µM) caused
a significant inhibition towards the ATP-evoked Ca2+ response by 52.9 ± 1.99% (n = 3; p < 0.01;
Figure 5A) and 78.5 ± 3.23% (n = 3; p < 0.001; Figure 5C), respectively. In addition to inhibiting the
peak magnitude of the Tg-resistant Ca2+ response, both antagonists also abolished the second slower
response observed in the presence of Tg (Figure 5B,D). Finally, pre-treatment of THP-1-differentiated
macrophages with P2X1 (Ro0437626; 30 µM) or P2X7 (A438079; 5 µM) antagonists had no inhibitory
effect on Tg-resistant Ca2+ responses (Figure 5E,F, respectively).
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and (C,D) THP-1 differentiated macrophages (n = 6); (E) time-response curve of the effect of Tg on 
100 μM ATP in the presence and absence of extracellular Ca2+ (n = 6); (F) effect of 5 μM Tg on basal 
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Figure 4. Investigating the contribution of P2X4 receptor using the positive allosteric modulator 
ivermectin. (A,B) effect of 3 μM IVM on Tg-resistant Ca2+ response represented as bar chart and time-
response curve, respectively (n = 6). The effect of 3 μM ivermectin (IVM) on: (C) decay kinetics (n = 6) 
and (D) net calcium movement as quantified by area under the curve (n = 6) of THP-1 differentiated 
macrophages. Asterisks include significant changes towards control (*** p < 0.001). 
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Figure 5. Effect of selective P2X receptor antagonists on Tg-resistant ATP-evoked Ca2+ response in 
THP-1 differentiated macrophages. (A,B) effect of P2X4 receptor antagonist (10 μM 5-BDBD) on 
magnitude of Ca2+ response and net calcium movement on Tg-resistant Ca2+ response (n = 3); (C,D) 
effect of P2X4 receptor antagonist (10 μM PSB-12062) on magnitude of Ca2+ response and net calcium 
movement on Tg-resistant Ca2+ response (n = 3); (E) effect of P2X7 receptor antagonist (5 μM A438079) 
represented as time response traces (n = 3); (F) effect of P2X1 receptor antagonist (30 μM Ro0437626) 
represented as time response traces (n = 3). Asterisks include significant changes towards control  
(*** p < 0.001, ** p < 0.01). 
2.4. Silencing of P2X4 Abolished Tg-Resistant Calcium Response and Reduced Sensitivities Towards IVM 
and PSB-12062 
The data so far illustrated that P2X4 receptors contribute towards the Tg-resistant ATP-evoked 
intracellular Ca2+ level. To provide further confirmation, a molecular-based approach to silence the 
P2X4 gene was employed. The success of the gene silencing technique was confirmed by the qRT-
PCR approach (48.8 ± 9.64% knockdown; n = 3; p < 0.01; Figure 6A) and flow cytometry (57.7 ± 4.37% 
reduction in cells expressing extracellular P2X4; n = 3; p < 0.01; Figure 6B). Despite a reduction in cell 
surface expression of P2X4 receptor, no significant changes in 100 μM ATP-evoked intracellular Ca2+ 
responses were observed in the P2X4-shRNA cells when compared to scrambled cells (Figure 6C). 
However, silencing of P2X4 significantly reduced the Tg-resistant ATP-evoked Ca2+ response in THP-
1-differentiated macrophages (F ratio 0.14 ± 0.02 ATP + Tg scrambled shRNA vs. F ratio 0.02 ± 0.014 
ATP + Tg P2X4 shRNA; n = 3; p < 0.001; Figure 6D). The effect of IVM and PSB-12062 was assessed on 
the P2X4 shRNA cells. When compared to scrambled negative control cells (Figure 7A,B), P2X4 
shRNA cells were found to be less sensitive towards both IVM and PSB-12062, as quantified using 
area under the curve (Figure 7B). While IVM caused a potentiation towards the net calcium 
movement of scrambled shRNA cells by 2.06 ± 0.23 fold (n = 3; p < 0.01; Figure 7A,B), IVM was only 
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2.4. Silencing of P2X4 Abolished Tg-Resistant Calcium Response and Reduced Sensitivities Towards IVM
and PSB-12062
The data so far illustrated that P2X4 receptors contribute towards the Tg-resistant ATP-evoked
intracellular Ca2+ level. To provide further confirmation, a molecular-based approach to silence the P2X4
gene was employed. The success of the gene silencing technique was confirmed by the qRT-PCR approach
(48.8± 9.64% knockdown; n = 3; p < 0.01; Figure 6A) and flow cytometry (57.7± 4.37% reduction in cells
expressing extracellular P2X4; n = 3; p < 0.01; Figure 6B). Despite a reduction in cell surface expression of
P2X4 receptor, no significant changes in 100 µM ATP-evoked intracellular Ca2+ responses were observed
in the P2X4-shRNA cells when compared to scrambled cells (Figure 6C). However, silencing of P2X4
significantly reduced the Tg-resistant ATP-evoked Ca2+ response in THP-1-differentiated macrophages
(F ratio 0.14 ± 0.02 ATP + Tg scrambled shRNA vs. F ratio 0.02 ± 0.014 ATP + Tg P2X4 shRNA;
n = 3; p < 0.001; Figure 6D). The effect of IVM and PSB-12062 was assessed on the P2X4 shRNA cells.
When compared to scrambled negative control cells (Figure 7A,B), P2X4 shRNA cells were found to be
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less sensitive towards both IVM and PSB-12062, as quantified using area under the curve (Figure 7B).
While IVM caused a potentiation towards the net calcium movement of scrambled shRNA cells by
2.06 ± 0.23 fold (n = 3; p < 0.01; Figure 7A,B), IVM was only able to potentiate the net calcium movement
of P2X4 shRNA cells by 1.53 ± 0.055 fold (n = 3; p < 0.01; Figure 7C,D). These data provide further
evidence that P2X4 receptor contributes towards Ca2+ influx in THP-1-differentiated macrophages and
that both IVM and PSB-12062 are useful tools for the study of P2X4.
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Figure 6. Loss of Tg-resistant ATP-evoked Ca2+ response in P2X4 knockdown THP-1 differentiated
macrophages. (A,B) quantification of P2X4 knockdown level in THP-1 differentiated macrophages
as measured using qRT-PCR for mRNA expression (n = 3) and flow cytometry for extracellular P2X4
protein expression (n = 3), respectively. Knockdown level was quantified against negative control
scrambled cells; (C) ATP-evoked Ca2+ response at 100 µM on scrambled shRNA and P2X4 shRNA
THP-1 differentiated macrophages (n = 4); (D) effect of Tg on 100 µM ATP response in scrambled
versus P2X4 shRNA THP-1 differentiated macrophages (n = 3). Asterisks include significant changes
towards control (* p < 0.05, ** p < 0.01, *** p < 0.001).
2.5. argeting eceptor rafficking to Investigate 2 4 ontribution to ards g- esistant alciu Response
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a significant delay in the decay kinetics (16.2 ± 1.20 s vs. 81.5 ± 7.03 s; n = 3; p < 0.001; Figure 8B)
and a sig ificant increase i the net calcium ovement as quantified by area under the curve (AUC
19.9 ± 2.02 without dynasore vs. 33.36 ± 5.56 with dynasore; n = 3; p < 0.05; Figure 8C). Pre-treatment
of cells with 1 µM vacuolin-1 had o significant effect on the magnitude of the Tg-resistant ATP-evoked
Ca2+ respo se in THP-1-differentiated macrophages (Figure 8D).
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3. Discussion
The expression of P2X receptors is widespread within the immune system, in particular P2X4 and
P2X7 [6]. Despite this observation, there has been no clear evidence of the contribution of P2X4 receptor
activation towards ATP-evoked Ca2+ influx in monocytes and macrophages. Since THP-1 monocytes
and THP-1 differentiated macrophages are frequently used as an experimentally amenable model
of human monocytes and macrophages [14–16], we utilized these model systems to investigate the
aforementioned issue. Through qRT-PCR analysis, the present study illustrated that both THP-1 and
THP-1 differentiated macrophages expresse all P2X receptors at the mRNA level with the exception of
P2X2 for THP-1 and P2X2 and P2X3 for THP-1 differentiated macrophages. It was also interesting to
observe that PMA differentiation of THP-1 into the model macrophage caused a downregulation of
P2X1 and P2X2 mRNA expression while an upregulation of P2X4 mRNA expression was observed.
To date, there is no reported comparison of mRNA expression level between THP-1 monocytes
and THP-1 differentiated macrophages. However, our findings corroborated previously reported
evidence by Myrtek et al. (2008) illustrating the expression of all P2X receptors except for P2X2,
P2X3 and P2X6 [17]. Protein expression of P2X1, P2X4, P2X5 and P2X7 was further confirmed by
immunocytochemistry analysis for both cell models.
To investigate the contribution of P2X4 receptor activation towards ATP-evoked intracellular Ca2+
responses in THP-1 monocytes and THP-1 differentiated macrophages, we employed intracellular Ca2+
measurements with the aid of various pharmacological tools. ATP elicited a concentration-dependent
increase in intracellular Ca2+ level in both cells but with significantly different response characteristics.
First, the peak magnitude of ATP-evoked Ca2+ responses was significantly larger in THP-1 monocytes,
compared to THP-1 differentiated macrophages. Secondly, decay kinetic response in THP-1 cells was
found to be significantly slower than that observed in THP-1 differentiated macrophages. Although the
factors underlying these differences were not investigated further, several speculations can be made.
The difference in peak magnitude may be a result of the different expression of P2Y receptors expressed
on the cell surface of the two cell types. This is a plausible explanation as P2Y receptor activation
has previously been reported as being responsible for mediating the first initial intracellular Ca2+
peak response [18,19]. A second plausible explanation would be the difference in ectoenzyme CD39
expression, responsible for the breakdown of ATP into ADP and AMP. Although monocytes and
macrophages are reported to express ectoenzymes CD39 and CD73, there has been no direct comparison
on the level of their expression [20,21]. On the other hand, the difference in decay kinetics of the two
cells in response to ATP stimulation may be a result of the different buffering capacity of Ca2+ of the
two cells. Previous studies revealed that antibody/FcR generated phagocytosis in macrophages is a
process that relies on increase in cytosolic Ca2+ concentration [22,23]. Therefore, as macrophages are
professional phagocytes, they may be more equipped to adapt to the changes in Ca2+ level.
As ATP elicits global P2 responses constituting of P2X and P2Y receptors, we utilized a SERCA
inhibitor, Thapsigargin (Tg), to deplete the intracellular stores of Ca2+ to eliminate mobilization of Ca2+
from intracellular stores by P2Y receptors [24,25]. Interestingly, pre-treatment of THP-1 monocytes with
5 µM Tg completely abolished the ATP-evoked Ca2+ response, suggesting that it is entirely dependent
on metabotropic P2Y receptor activation. The same treatment in THP-1 differentiated macrophages
resulted in a significant inhibition of the ATP-evoked Ca2+ response, leaving a small Tg-resistant
component, which was dependent on Ca2+ influx. Due to the lack of Tg-resistant Ca2+ response, we did
not pursue investigation into THP-1 monocytes and focused on THP-1 differentiated macrophages
instead. Our study provides evidence regarding the contribution of P2X4 receptor towards ATP-evoked
Ca2+ response in THP-1 differentiated macrophages. This was evident from the effect observed by
the use of positive allosteric modulator ivermectin (IVM) [26] and selective P2X4 receptor antagonists
5-BDBD and PSB-12062 [27–30]. Pre-treatment of THP-1 differentiated macrophages with 3 µM
IVM caused a significant potentiation towards the peak magnitude of Tg-resistant Ca2+ response,
accompanied by a significant delay in decay kinetics. It has been previously reported that the main
characteristics of the IVM effect on P2X4 receptors include potentiation in magnitude and delay in
Int. J. Mol. Sci. 2017, 18, 2261 10 of 13
decay current, although studies by Norenberg et al. (2012) illustrated that only the effect on decay
kinetics is specific to P2X4 receptors [26,28]. The effects of 5-BDBD and PSB-12062 on Tg-resistant Ca2+
response was also consistent, in which they both significantly reduced the peak magnitude as well
as abolished the second slower response. Despite similar effect in inhibition, PSB-12062 appeared to
be more potent in causing an inhibition towards the Tg-resistant Ca2+ response, and this may be due
to the nature of the antagonists. While PSB-12062 has been described as an allosteric antagonist [28],
5-BDBD is thought to act competitively, which implies that its effect may be masked due to the high
agonist concentration used throughout the study (100 µM ATP). Finally, the contribution of P2X4
receptor activation towards ATP-evoked Ca2+ response was confirmed with a knockdown approach,
which illustrated that P2X4 knockdown THP-1 differentiated macrophages lacked a Tg-resistant
ATP-evoked Ca2+ response as well as reduced sensitivities towards IVM and PSB-12062.
As P2X1, P2X4 and P2X7 are all expressed in the immune cells [31,32], we also investigated
the contribution of P2X1 or P2X7 towards the Tg-resistant Ca2+ response. Selective P2X1 antagonist
Ro0437626 and P2X7 antagonist A438079 had no significant inhibitory effect towards the Tg-resistant
ATP-evoked Ca2+ response in THP-1 differentiated macrophages. The lack of contribution of P2X1
in ATP-evoked Ca2+ response in these cells contradict previous studies reported by Sim et al. and
Wareham et al. illustrating functional evidence of P2X1 receptor in mouse macrophages [33] and
human lung mast cells [31], respectively. Our qRT-PCR data illustrated that mRNA expression of
P2X1 receptors in THP-1 differentiated macrophages is downregulated compared to THP-1 monocytes.
It may therefore be interesting to investigate if this downregulation translates at the protein level,
therefore being responsible for the lack of P2X1 contribution in these cells. Unlike P2X1, the lack of
P2X7 receptor contribution towards ATP-evoked Ca2+ response in THP-1 differentiated macrophages
is not as surprising. It is well established that 100 µM ATP used through this study is significantly
below the activation threshold for P2X7 receptors (>500 µM) [34–36].
Altogether, the data provides evidence that P2X4 is functionally expressed in THP-1 differentiated
macrophages as reflected from their contribution towards ATP-evoked Ca2+ response, but their
functional evidence in THP-1 monocyte is lacking. Studies by Li et al. have previously reported
functional P2X4 in THP-1 monocytes, although, in this case, PLC inhibitor U-73122 was used instead
of Tg [12]. Furthermore, through intracellular Ca2+ measurements, we have showed that IVM and
PSB-12062 are reliable tools for the study of P2X4, supported with findings from P2X4 knockdown cells.
4. Experimental and Materials
4.1. Chemicals and Reagents
The following reagents were used: PSB-12062 and ATP (Sigma-Aldrich, St. Louis, MO, USA),
A438079 (Abcam, Cambridge, UK), Ivermectin, 5-BDBD, Ro0437626 and Thapsigargin (all from Tocris,
Bristol, UK), and Fura 2-AM (TefLabs, Austin, TX, USA).
4.2. Cells
THP-1 cells were obtained from the European Collection of Cell Cultures (ECACC). Human THP-1
cells were cultured in Roswell Park Memorial Institute (RPMI) 1640 medium with 2 mM L-glutamine,
10% foetal bovine serum (FBS) and 50 IU/mL penicillin and 50 µg/mL streptomycin. Cells were
maintained at 37 ◦C with 5% CO2 in a humidified incubator. To generate THP-1 differentiated
macrophages, cells were stimulated with 320 nM of phorbol 12-myristate 13-acetate (PMA) for 48 h at
37 ◦C, 5% CO2 in a humidified incubator.
4.3. Intracellular Ca2+ Measurements
Cells at 2 × 105/well were loaded for 1 h at 37 ◦C with 2 µM Fura-2 AM. Cells were washed
twice with physiological saline (SBS) buffer. Measurements were performed at 37 ◦C on a 96-well
plate reader (FlexStation III, Molecular Devices, Sunnyvale, CA, USA). The change in intracellular
Int. J. Mol. Sci. 2017, 18, 2261 11 of 13
Ca2+ concentration is indicated as a ratio of fura-2 emission intensities for 340- and 380-nm excitation
(F ratio). SBS buffer contained (mM): 130 NaCl, 5 KCl, 1.2 MgCl2, 1.5 CaCl2, 8 D-glucose, 10 HEPES;
pH 7.4. Ca2+-free SBS was prepared by excluding CaCl2 and supplemented with 2 mM ethylene
glycol-bis(β-aminoethyl ether)-N,N,N′,N′-tetraacetic acid (EGTA). Loading of cells with Fura 2-AM
was performed in SBS buffer supplemented with 0.01% (w/v) pluronic acid. All compounds were
pre-treated onto cells for 30 min before Ca2+ measurements.
4.4. RNA Extraction and cDNA Synthesis
Total RNA was isolated from cells using TRI Reagent (Sigma Aldrich, St. Louis, MO, USA)
and contaminating genomic DNA was eliminated using DNA-free kit (Ambion, Foster City, CA,
USA). cDNA was synthesized from 0.5 µg of total RNA using SuperScript II reverse transcriptase kit
(Invitrogen, Waltham, MA, USA).
4.5. Quantitative Real-Time PCR
Taqman primer probes sets for human P2X1 (Hs00175686_m1), P2X2 (Hs04176268_g1), P2X3
(Hs01125554_m1), P2X4 (Hs00602442 _m1), P2X5 (Hs01112471_m1), P2X6 (Hs01003997_m1), P2X7
(Hs00175721 _m1), β-actin (Hs01060665_g1) were obtained pre-designed from Applied Biosystems
(Foster City, California, USA). qRT-PCR was performed in a 7500 Fast Real-Time PCR instrument
(Applied Biosystems). Target gene expression was normalized to β-actin endogenous control and
relative quantification was done by the ∆∆Ct method.
4.6. Generating Knockdown P2X4 THP-1 Cells
THP-1 cells (2.5 × 105) were transduced with either scrambled shRNA or P2X4 shRNA lentiviral
particles (Thermo Scientific, Loughborough, UK) in the presence of 8 µg/mL hexadimethrine bromide
and Lipofectamine 2000 (Thermo Fisher, Loughborough, UK).
4.7. Immunocytochemistry
Cells at 2.5 × 104/mL were fixed with 4% paraformaldehyde (15 min, RT) and permeabilized
with 0.25% Triton X-100 (10 min, RT). Cells were blocked with 1% bovine serum albumin (30 min,
RT) and incubated overnight at 4 ◦C with primary antibodies (rabbit polyclonal P2X4 (Alomone,
Jerusalem, Israel), goat polyclonal P2X1,5,7 (Santa-Cruz biotechnology, Dallas, TX, USA). Cells were
stained with secondary antibody goat anti-rabbit (Life Technologies, Waltham, MA, USA) or rabbit
anti-goat (Abcam, Cambridge, UK) AF488. Nuclear staining was performed with Vectashield Antifade
containing DAPI (Vectorlabs, Peterborough, UK). Cell imaging was performed using laser-scanning
confocal microscope Zeiss LSM510 META (Zeiss, Oberkochen, Germany).
Flow cytometry—Cells (100 µL at 1 × 106/mL) were incubated for 10 min at room temperature
(RT) with Fc block (BD, San Jose, CA, USA) and immunostained with anti-human P2X4 (Alomone,
Jerusalem, Israel) or hIgG isotype control (Life Invitrogen, Waltham, MA, USA) followed by AlexaFluor
488 (AF488) (Life Invitrogen, Waltham, MA, USA). Cells were acquired on the Cytoflex instrument
(Beckman Coulter, Franklin Lakes, NJ, USA). Analyses were performed on CytExpert software
(Beckman Coulter, Franklin Lakes, NJ, USA).
Statistical analysis—Data were analyzed using Origin Pro 9.0 software (Origin Lab, Northampton,
MA, USA). Concentration-response curves were fitted assuming a Hill coefficient of 1. Hypothesis
testing for experiments with paired datasets were performed by means of paired Student’s t-test using
Origin Pro 9.0. Data are expressed as mean ± SEM of at least three independent experiments.
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